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Abstract 
 
Graphene-based materials are being widely explored for a range of biomedical 
applications, from targeted drug delivery to biosensing, bioimaging and use for 
antibacterial treatments, to name but a few. In many such applications it is not 
graphene itself that is used as the active agent, but one of its chemically-
functionalised forms. The type of chemical species used for functionalisation will play 
a key role in determining the utility of any graphene-based device in any particular 
biomedical application, since this determines to a large part its physical, chemical, 
electrical and optical interactions. However, other factors will also be important in 
determining the eventual uptake of graphene-based biomedical technologies, in 
particular the ease and cost of manufacture of proposed device and system designs. 
In this work we describe three novel routes for the chemical functionalisation of 
graphene using oxygen, iron chloride and fluorine. We also introduce novel in-situ 
methods for controlling and patterning such functionalisation on the micro- and nano-
scales. Our approaches are readily transferable to large-scale manufacturing, 
potentially paving the way for the eventual cost-effective production of functionalised 
graphene-based materials, devices and systems for a range of important biomedical 
applications.     
 
 
  
1. Introduction 
 
The biomedical applications of graphene-based materials are wide-ranging 
and potentially of much importance and impact, spanning, for example, drug 
delivery, photothermal therapy, tissue engineering, bactericides, biosensing and 
bioimaging [1]. Such wide-ranging applicability of graphene arises from its unique 
physical, electrical, mechanical and chemical properties, in particular its high surface 
area, excellent electrical and thermal conductivity, optical transparency, 
biocompatibility and, importantly, its ease of functionalisation. Indeed, for many 
biomedical applications it is not graphene per se that is used as the active material, 
but rather a functionalised form of graphene, where functionalisation with particular 
chemical species has been carried out in order to enhance performance and 
increase selectivity (e.g. to a particular reaction). One of the most widely used 
functional groups is simple oxygen, which yields of course graphene oxide, or GO. 
For example GO (and reduced-GO) has been used extensively for drug delivery in 
cancer treatment (see e.g. [2-4]), for the fabrication of biosensing platforms capable 
of detecting the presence of key disease biomarkers and DNA sequences (see e.g. 
[5-7]), for the in-situ bioimaging of cells [8], as well as finding application as a most 
effective antibacterial agent (see e.g [9-11]). Oxygen is however not the only useful 
species for graphene functionalisation, far from it. We ourselves, for example, have 
shown that functionalisation of few-layer graphene (FLG) with iron chloride (FeCl3) 
leads to exceptional photoelectrical properties [12] that can be exploited in a wide 
variety of applications, including highly sensitive and high-resolution photodetectors 
for biosensing and bioimaging.  Fluorine-functionalised graphene has also been 
shown to possess very useful biomedical applications, particularly for the detection 
of various analytes and biomarkers [13], and may ultimately find application in the 
the management and detection of a range of important and widespread health 
problems, such as diabetes and cardiovascular disease. 
In this study we report on the functionalisation of graphene using the three 
chemical species introduced above, namely oxygen, iron chloride and fluorine. In 
particular we report on novel ways for localising such functionalisation, potentially 
down to the nanoscale. The ability to exert local control of the functionalisation 
process and to pattern functionalised regions as desired in a simple and effective 
way, which we demonstrate here, should make for more straightforward and cost-
effective production of future graphene-based biomedical devices.   
 
 
2. New routes to oxygen-functionalised graphene devices 
The efficient and cost-effective production of functionalised graphene devices 
is still hampered somewhat by conventional approaches to device fabrication. Such 
conventional approaches involve several process steps including graphene 
deposition, graphene film transfer, graphene functionalisation, ex-situ lithographic 
patterning and metal contact deposition; processes that are time consuming, not 
always reproducible and potentially deleterious to the properties of the CVD-
graphene layer itself (see e.g. [14-16]). An alternative approach that avoids many 
such drawbacks is to carry out in-situ plasma functionalization and in-situ lithographic 
patterning of large-area CVD graphene directly on the copper substrates used in the 
graphene deposition process. This enables the fabrication of devices in their entirety 
prior to any transfer steps. Here we concentrate on the production of oxygen 
(plasma) functionalised graphene materials and devices which, as discussed in the 
introduction above, have found widespread application in the biomedical field.   
The plasma oxidation method for the production of graphene oxide has 
several advantages cf. the more commonly used liquid-phase approaches (such as 
the Hummer’s method). In particular, plasma-oxidation does not contaminate 
samples with by-products of (wet) chemical reactions [17, 18], it is easily scaled in 
size, it is relatively environment-friendly and involves fewer stages as compared to 
conventional methods [19]. Moreover, patterned graphene/graphene oxide structures 
and devices can also be readily created using plasma modification of graphene 
combined with lithographic processing, and this can all be carried out prior to the 
transfer, onto the desired substrate, of the (functionalised and patterned) graphene 
from its CVD (catalytic) Cu foils. In this way complex micro- and nano-scale GO 
device structures can be reliably fabricated in fewer steps than via conventional 
approaches and, importantly, be readily transferred onto a range of target surfaces 
including rigid and flexible substrates, biocompatible substrates and even textiles 
(for, e.g. wearable biomedical devices). 
Our novel fabrication process is illustrated in figure 1, here using an 80 x 80 
µm GO logo (a G surrounded by an O) by way of demonstration (and in which the G 
and O regions are plasma-oxidised while the remainder of the film remains as 
graphene). In detail the our process consists the following: first, a 200 nm thick layer 
of positive e-beam resist (PMMA) is spin coated onto graphene film on copper foil, 
as grown by the CVD method; next, the area to be functionalised is exposed by e-
beam and subsequently developed, leaving the unmasked regions of the graphene 
film exposed; next the sample is exposed to the oxygen plasma; then, the copper 
substrate is etched away from the underside using ammonium persulphate solution; 
the PMMA-graphene stack is cleaned multiple times in de-ionized water and then 
transferred onto the target substrate; finally, the PMMA mask is removed using 
acetone and the sample is cleaned with isopropyl alcohol. To verify that the G and O 
patterned regions, and only those regions, were successfully oxidised, we carried out 
Raman mapping of the sample (with a 1 µm step size) and plot, in figure 1g, the ratio 
of the intensities of the Raman D and G peaks (ID/IG). It can be seen that a striking 
ID/IG contrast exists between the oxidised regions and those that were protected from 
the plasma, indicating successful oxidation of the desired regions.  The oxidized ‘GO 
logo’ pattern of figure 1g can also be clearly seen via SEM imaging, as shown in 
figure 1h, the darker regions in that image indicating a reduction of the conductivity 
of the plasma exposed area. 
Although we have here shown the production of a simple logo to demonstrate 
on the micron-scale the effective local functionalisation of graphene (to graphene 
oxide), it is straightforward to use the technique we have presented to fabricate 
entire devices with features down to the nanoscale if desired. For example, we have 
previously successfully produced a flexible and transparent plasma functionalised 
graphene/graphene oxide humidity sensor that outperformed high-grade commercial 
humidity sensors [20]. The production of biomedical-oriented devices using our 
technique is also entirely feasible and could prove particularly beneficial in the 
biosensing area. Moreover, while we in this section have concentrated on oxygen 
plasma functionalisation, the approach described is generic and can undoubtedly be 
applied in the case of functionalisation by other chemical species.  
 
 
 
 
 
Figure 1. Schematic representation of the in-situ functionalisation (here using oxygen) and 
patterning of as-grown CVD graphene: (a) to (b) photoresist (PMMA) coating of as-grown 
CVD graphene; (b) to (c) e-beam lithography on Cu; (c) to (d) plasma oxidation (in a reactive 
ion etching system); (d) to (e) copper etching in APS solution; (e) to (f) graphene transfer 
onto the target (here shown as a flexible) substrate. (g) and (h) show a Raman ID/IG map and 
SEM image of the final 80 x 80 µm GO logo [Adapted and reprinted with permission from 
[20]; Copyright IoP 2016] 
 
 
3. New routes to patterning FeCl3-functionalised graphene for high-definition 
bioimaging and biosensing 
Optoelectronic biosensing platforms are attracting growing interest as they 
can potentially be incorporated in portable medical devices to be used in a 
multiplicity of environments [21]. In general, such platforms are based on a light 
source, a reactive medium and a photodetector with spectral selectivity. Thus, 
photodetectors for high-definition sensing and imaging and able to operate in various 
spectral ranges are needed. In particular, infrared (IR) and near infrared (NIR) 
detectors have applications in biochemical detection and functional-NIR medical 
imaging. On the other hand, ultraviolet (UV) light is strongly absorbed by many 
materials, enabling the observation of characteristics that are difficult to detect by 
other methods. For example, UV imaging is an emerging inspection method for 
microbial contamination of food products. Several alternative approaches for 
optoelectronic biosensing have been demonstrated in recent years based, for 
example, on plasmonic nano-resonators [22], optofluidic devices [23] or integrated 
semiconductor photodetectors [24, 25]. However, the push for the development of 
low-cost, flexible and wearable devices [26] has instigated the exploration of novel 
materials, amongst which is graphene [27,28] and its functionalised forms.  
While in the previous section we concentrated on oxygen functionalisation, we 
now turn our attention to the functionalisation of few-layer graphene with FeCl3. This 
results in the best transparent electrical conductor currently available [12], and one 
that outperforms indium tin oxide (ITO) as currently used extensively in touch screen 
displays etc. However, FeCl3 functionalised graphene is much more than just a high-
performance transparent conductor, it offers a gamut of exciting properties and 
potential for various applications. Examples include an unforeseen stability to harsh 
environmental conditions [29], ease of large-area processing [30], the realisation of 
all-graphene photodetectors [31] and the potential to enhance the efficiency of 
photovoltaic and organic light emitting devices [30, 32]. When used as a transparent 
electrode in electroluminescent devices, FeCl3 functionalised graphene also 
increases the brightness of the emitted light by up to 50% as compared to pristine 
graphene, and up to 30% compared to state-of-the-art commercial electrodes [33]. 
Furthermore, the record high charge density achieved in FeCl3 functionalised 
graphene [12, 34] makes it an attractive platform for the production of high-
responsivity, high-resolution photodetectors.  
Graphene-enabled high resolution imaging could open a new era in small-
footprint high-performance biosensing devices. However, the scientific community is 
presently facing difficult challenges in realising such devices. In particular, efficient 
nano-scale graphene photodetectors are presently not possible due to the 
dominance of photo-thermoelectric effects (PTE) in graphene, which sets the 
minimum size for a graphene pixel to the tens of micron scale (as demonstrated by 
several pioneering works [35-39]). Another obstacle is imposed by the diffraction 
limit, setting a further constraint on the (minimum) size of devices. Furthermore, the 
electrical and optical properties of graphene are severely hampered by 
contamination of the material in ambient conditions, requiring elaborate ways of 
encapsulation to preserve the properties of graphene, so limiting its use in realistic 
situations [40].  
Many of the above issues have been recently tackled using FeCl3-intercalated 
few-layer graphene [12, 29-34] (FeCl3-FLG), together with a new way to define 
optically active junctions [41]. As shown in figure 2a, a laser beam is used to control 
the microscopic arrangement of FeCl3 molecules which are intercalated between 
sheets of graphene, in order to define photoresponsive junctions. This approach 
enables conceptually new ways to capture and manipulate light beyond conventional 
plasmonic structures. Intercalation of graphene with FeCl3 results in a strong charge-
transfer [12, 30] and consequent p-type doping of the graphene. By selectively 
removing FeCl3 molecules, therefore, a p-p' junction can be defined, as shown in 
figure 2b, (where the total charge concentration in the graphene stack is shown 
before and after laser-irradiation of a strip across the sample [30, 42]). Such a 
junction shows a strong photoresponse, as shown by the scanning-photocurrent 
maps in figure 2c. By analysing the direction of the observed photocurrent and 
calculating the different contributions to the photocurrent arising from the PTE and 
photovoltaic (PV) effects, it is shown that in FeCl3-intercalated graphene strong 
quenching of PTE effects is possible and the photoresponse is dominated by the PV 
effect [41].  
The quenching of the PTE effect in FeCl3-FLG removes one of the key 
limitations, in terms of device-scaling and hence sensing and imaging resolution, of 
graphene-only photodetectors. Indeed, the quenching of the PTE effect in FeCl3-FLG 
allows the definition of photoactive junctions in a much more confined space. To this 
end, emerging nano-photonics near-field techniques [43] can be used in order to 
surpass the other ‘block’ on high-resolution sensing and imaging, namely the 
diffraction limit. For example, in figure 2d and 2e a red (= 632 nm) laser focused 
onto a metallic atomic-force microscope AFM tip is used to define a photoactive p-p' 
junction with a peak-to-peak distance of only 250 nm, less than half the laser 
wavelength used. The broad spectral response of graphene is also maintained in 
these sub-diffraction FeCl3-FLG devices, which show a consistent proportionality 
between optical response and photon energy from the ultraviolet (UV) right through 
to mid-infrared (MIR) wavelengths. Another extraordinary characteristic of laser 
patterned FeCl3-FLG junctions is their linear dynamic range (LDR). This parameter 
determines the range of power densities over which a photodetector's response is 
linear. In graphene such linearity is limited by the aforementioned PTE effect and the 
small density of states (DOS) available for photoexcitation. In FeCl3-FLG, instead, a 
LDR of 44 dB is observed. This is a remarkable 4500 times larger than any other 
graphene-based photodetector reported to date [41].  
 
Figure 2: Laser-written photodetectors in FeCl3-intercalated graphene. (a) Device structure 
and scanning photocurrent measurement configuration (top) of a p-p'-p junction. The 
selective displacement of FeCl3 molecules with laser light allows the formation of a p region 
(in green). The schematic band structure (bottom) of each region illustrates how photo-
generated carriers drift under the induced chemical potential gradient. (b) Total charge 
carrier concentration in pristine and laser-irradiated FeCl3-FLG. (c) Scanning photo-current 
maps of a FeCl3-FLG flake (red-dashed lines) with Au contacts (yellow lines) before and 
after laser-assisted displacement of FeCl3 (white-dashed lines). (d) Near-field patterning of 
photoactive junctions in FeCl3-FLG. AFM topography (left) and scanning photocurrent map 
(right) of the flake after laser irradiation by a = 632nm laser (white dashed lines). Insets: 
illustrations of the chemical structure in p- and p-doped regions. (e), Line scans of 
photocurrent measured across the laser defined p-p'-p junctions. Bottom panel shows first 
derivative plots of the photocurrent signal, indicating a peak-to-peak distance of only 250 nm 
between adjacent junctions. [Adapted and reprinted with permission from [41]; copyright 
AAAS 2017]  
To summarise, by using FeCl3 functionalisation of graphene we can ‘engineer’ 
the hot carrier photoresponse so as to enhance both pixel resolution and linear 
dynamic range, whilst at the same time maintaining a broad spectral response, in 
atomically thin devices and systems. Such capabilities could have potentially wide-
reaching impacts on technologies for spectroscopy, high definition bioimaging and 
biosensing. We might see their use in, for example, disposable medical diagnostic 
tools for the detection of biofluorescent molecules with sub-wavelength resolution 
[44], or in skin-conformable photodetectors for heart rate measurements (known as 
photoplethysmography), or perhaps wearable and elastic UV cameras for minimally-
invasive probes and UV tracking.  
 
 
4. Nano-patterning of fluorine-functionalised graphene for biosensing 
Yet another biologically-useful functionalisation of graphene is that using fluorine. In 
fluorinated graphene, fluorine adatoms are covalently bonded to the carbon atoms 
and, owing to the high electronegativity of the bound fluorine, FG benefits from an 
augmented sensing performance for various analytes and biomarkers [45]. Previous 
studies have also revealed that sensing activity strongly depends on the fluorine 
content [46]; the interactions between FG and biomolecules can be drastically 
modified by varying the amount of fluorine functionalisation. Hence controlling and 
tuning the fluorine content are important aspects for the further development of FG-
based biosensors. In particular, the possibility to control locally the fluorine content 
would enable a new concept of biosensing applications whereby a wide variety of 
biomolecules can be detected at different positions on the same sensor by patterning 
the degree of functionalisation.  
 We have shown that such local control of fluorination can be achieved by 
starting off from a highly fluorinated graphene sheet and reducing the level of 
functionalisation in specific regions by irradiation with an electron beam [47, 48]. This 
approach is summarised in figure 3. The starting material is a sheet of functionalised 
graphene obtained by exposure to F2 gas at 450oC, resulting in a fluorine content of 
28%. Subsequently, irradiation of the functionalised graphene with an electron beam 
with appropriate energy dissociates the C–F bonds, so reducing the level of 
fluorination. This innovative technique offers a simple and direct way to pattern 
spatially, on the nano-scale, the degree of fluorination. This has also been 
experimentally confirmed by the demonstration that the value of the energy gap of 
fluorinated graphene depends on the F content. As shown in figure 3d, a transition 
from a semiconductor (i.e. FG) to a semi-metal (i.e. graphene) was experimentally 
observed upon changing in-situ the F-coverage from 28% to <1% using electron 
beam irradiation. A significant change in the resistivity of FG has been shown to 
accompany this transition. It was found that the relative decrease in resistance per 
square upon electron-irradiation of micro-structures is at least seven orders of 
magnitude from 1TΩ to 100 kΩ. Furthermore, our process can be used for patterning 
different surface areas ranging from few tens of squared micrometres to channels 
just a few tens of nanometres wide (dependent on e-beam resolution).  
 In summary, the patterning of fluorine-functionalisation content in FG by 
means of electron beam irradiation offers novel avenues for biosensing. Sensing of 
various biological analytes has already been demonstrated using fluorinated 
graphene where the F content was varied. The implementation of FG biosensors 
where F content is tuned by electron beam patterning to different values across the 
same device would enable a new multi-functional biosensors whereby a wide variety 
of biomolecules can be detected in a single device, perhaps for the monitoring of 
biologically important analytes such as those needed for the management of 
diabetes and cardiovascular diseases (i.e. glucose, cholesterol, triglyceride, glycated 
haemoglobin).   
 
 
 
 
Figure 3. Nano-patterning fluorinated graphene. (a) Schematic illustration of the device 
configuration under irradiation with a beam of electrons. The fluorinated graphene 
(green) is reduced to graphene (grey) upon electron irradiation. (b) the sample resistance 
plotted against inverse width W for a device. The continuous line is a linear fit. (c) 
topographical AFM image for the unexposed (orange) and exposed (red) fluorinated 
graphene. The bottom panel illustrates the crystal structure of pristine graphene (gray) and 
fluorinated graphene (green). [Reprinted with permission from [47]; copyright American 
Chemical Society 2011]. (d) Graph of the measured zero-bias square resistance 
(Rsq) at room temperature after subsequent steps of electron assisted defluorination 
conducted on the same sample. The insets show the process of electron-assisted 
defluorination where fluorinated graphene (left structure with carbon atoms in grey and 
fluorine atoms in green) is reduced to graphene (right structure). [Reprinted with permission 
from [48]; copyright DPG/IoP 2013] 
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